One Stop Solution For In-Depth Market Research Reports

詳細な市場調査レポートのワンストップソリューション

Home    >    HEALTHCARE AND PHARMACEUTICALS   >   Clinical Laboratory Services Market

[ 英語タイトル ] Clinical Laboratory Services Market by Specialty (Biochemistry, Endocrinology, Microbiology, Hematology, Cytology, Histopathology, Genetic Testing), Providers (Independent Laboratory, Reference Laboratory, Hospital Laboratory) - Global Forecasts to 2022


Product Code : MNMHC00109188
Survey : MarketsandMarkets
Publish On : February, 2021
Category : Healthcare and Pharmaceuticals
Study Area : Global
Report format : PDF
Sales price option (consumption tax not included)
Single User USD5650 / Question Form
5 User USD6650 / Question Form
Enterprise User USD10000 / Question Form

[Report Description]

Clinical laboratory services market projected to grow at a CAGR of 5.2%

The clinical laboratory services market is projected to reach USD 146.14 billion by 2022 from USD 113.44 billion in 2017, at a CAGR of 5.2%. The increasing global burden of target diseases, advancements in clinical diagnostic techniques, and rising government initiatives to improve the quality and affordability of clinical diagnostic testing procedures are the major factors driving the demand for clinical laboratory services market. Factors such as the pricing pressure faced by healthcare payers and providers and the procedural shift from lab-based diagnosis to home-based/point-of-care testing procedures are limiting the growth of the market to a certain extent.

The genetic testing segment is expected to witness the highest growth during the forecast period
In 2017, on the basis of specialty, the genetic testing segment is expected to register the highest growth rate during the forecast period, due to growing adoption of precision medicine and increasing awareness among people about preventive care.
The independent & reference laboratories segment is poised to be the fastest growing during the forecast period
In 2017, on the basis of provider, the independent & reference laboratories segment is expected to register the highest growth rate during the forecast period, owing to a global focus on patient diagnosis for target diseases worldwide and the competitive benefits offered by providers over hospital-based laboratories.

Asia Pacific is expected to register the highest growth rate during the forecast period
Geographically, the clinical laboratory services market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. Asia Pacific is expected to register the highest growth rate during the forecast period owing to rising penetration of cutting-edge clinical laboratory technologies among masses (especially in rural areas) in Asia Pacific countries, and a significant rise in the disposable income among their middle-class population.

Breakdown of supply-side primary interviews: by company type, designation, and region:
• By Company Type - Tier 1 – 48%, Tier 2 – 40% and Tier 3 – 12%
• By Designation – C-level – 26%, Director-level – 30%, Others – 44%
• By Region – North America - 34%, Europe – 26%, APAC – 23%, South America – 9% and Middle East – 8%

The global clinical laboratory services market is competitive, with a large number of global and local players. In 2016, the market was dominated by Mayo Medical Laboratories (US), LabCorp (US), and Quest Diagnostics (US). Service launches, upgrades, and approvals; agreements, partnerships, and collaborations were the major strategies adopted by market players to achieve growth in the market.

Research Coverage
This report studies the clinical laboratory services market based on specialty, provider, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth. It analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for the market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends, prospects, and contributions to the total market. The report forecasts the revenue of the market segments with respect to four main regions.

Reasons to Buy the Report:
This research report focuses on various levels of analysis—industry trends, market share analysis of top players, and company profiles, which together comprise and discuss the basic views on the competitive landscape, emerging and high-growth segments of the clinical laboratory services market, and high-growth regions and countries and their respective drivers, restraints, challenges, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn can help firms garner greater market shares. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies for strengthening their market shares.

The report provides insights on the following pointers:

• Market Penetration: Comprehensive information on service portfolios offered by the major players in the clinical laboratory services market. The report analyzes the clinical laboratory services market based on specialty, provider, and region
• New Service Development: Detailed insights on the research and development activities and service launches in the clinical laboratory services market
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various clinical laboratory services across geographies
• Market Diversification: Exhaustive information about new services, untapped geographies, recent developments, and investments in the clinical laboratory services market
• Competitive Assessment: In-depth assessment of market ranking, strategies, service portfolios, distribution networks, and providers capabilities of leading players in the clinical laboratory services market

TABLE OF CONTENTS

1 INTRODUCTION 14
1.1 OBJECTIVES OF THE STUDY 14
1.2 DEFINITION 14
1.3 MARKET SCOPE 15
1.3.1 MARKETS COVERED 15
1.3.2 GEOGRAPHIC SCOPE 16
1.3.3 YEARS CONSIDERED FOR THE STUDY 16
1.4 CURRENCY 17
1.5 LIMITATIONS 17
1.6 STAKEHOLDERS 17
2 RESEARCH METHODOLOGY 18
2.1 RESEARCH DATA 18
2.1.1 SECONDARY DATA 20
2.1.1.1 Secondary sources 20
2.1.2 PRIMARY DATA 21
2.1.2.1 Breakdown of primaries 22
2.1.2.2 Key data from primary sources 22
2.2 MARKET SIZE ESTIMATION 23
2.2.1 BOTTOM-UP APPROACH 23
2.2.2 TOP-DOWN APPROACH 24
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 25
2.4 ASSUMPTIONS FOR THE STUDY 26
3 EXECUTIVE SUMMARY 27
4 PREMIUM INSIGHTS 31
4.1 CLINICAL LABORATORY SERVICES MARKET OVERVIEW 31
4.2 CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY 32
4.3 CLINICAL LABORATORY SERVICES PROVIDER MARKET, BY REGION 33
4.4 GEOGRAPHIC SNAPSHOT: CLINICAL LABORATORY SERVICES MARKET 34
5 MARKET OVERVIEW 35
5.1 INTRODUCTION 35
5.2 MARKET DYNAMICS 35
5.2.1 DRIVERS 36
5.2.1.1 Increasing global burden of target diseases 36
5.2.1.2 Rising demand for early and accurate disease diagnosis 37
5.2.1.3 Advancements in clinical diagnostic techniques 37
5.2.1.4 Growing public-private investments as well as research funding & grants to develop innovative laboratory testing procedures 38
5.2.1.5 Rising government initiatives to improve the quality and affordability of clinical diagnostic testing procedures 39
5.2.2 RESTRAINTS 40
5.2.2.1 Pricing pressure faced by healthcare payers and providers 40
5.2.2.2 Procedural shift from lab-based diagnosis to home-based/point-of-care testing procedures 40
5.2.3 OPPORTUNITIES 41
5.2.3.1 Emerging countries 41
5.2.3.2 Patient-initiated diagnostic testing to foster market growth in developed countries 42
5.2.3.3 Growing adoption of digital pathology platforms 42
5.2.3.4 Rising preference for comprehensive health checkups offered by clinical laboratories 42
5.2.4 CHALLENGE 43
5.2.4.1 Public concerns related to data security and privacy 43
6 CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY 44
6.1 INTRODUCTION 45
6.2 CLINICAL CHEMISTRY TESTING 46
6.2.1 ROUTINE CHEMISTRY TESTING 48
6.2.2 ENDOCRINOLOGY CHEMISTRY TESTING 49
6.2.3 THERAPEUTIC DRUG MONITORING (TDM) TESTING 50
6.2.4 SPECIALIZED CHEMISTRY TESTING 51
6.2.5 OTHER CLINICAL CHEMISTRY TESTING 51
6.3 MICROBIOLOGY TESTING 52
6.3.1 INFECTIOUS DISEASE TESTING 55
6.3.2 TRANSPLANT DIAGNOSTIC TESTING 56
6.3.3 OTHER MICROBIOLOGY TESTING 57
6.4 HEMATOLOGY TESTING 58
6.4.1 ROUTINE HEMATOLOGY TESTING 60
6.4.2 COAGULATION TESTING 60
6.4.3 SPECIALIZED HEMATOLOGY TESTING 61
6.5 IMMUNOLOGY TESTING 62
6.6 CYTOLOGY TESTING 64
6.7 GENETIC TESTING 66
6.8 DRUGS OF ABUSE TESTING 68

7 CLINICAL LABORATORY SERVICES MARKET, BY PROVIDER 70
7.1 INTRODUCTION 71
7.2 INDEPENDENT & REFERENCE LABORATORIES 72
7.3 HOSPITAL-BASED LABORATORIES 73
7.4 NURSING AND PHYSICIAN OFFICE-BASED LABORATORIES 74
8 CLINICAL LABORATORY SERVICES MARKET, BY REGION 75
8.1 INTRODUCTION 76
8.2 NORTH AMERICA 77
8.2.1 US 80
8.2.2 CANADA 82
8.3 EUROPE 83
8.3.1 GERMANY 85
8.3.2 UK 86
8.3.3 FRANCE 87
8.3.4 REST OF EUROPE (ROE) 88
8.4 ASIA PACIFIC 90
8.4.1 JAPAN 92
8.4.2 CHINA 93
8.4.3 INDIA 94
8.4.4 REST OF ASIA PACIFIC (ROAPAC) 95
8.5 REST OF THE WORLD (ROW) 97
9 COMPETITIVE LANDSCAPE 100
9.1 OVERVIEW 100
9.2 MARKET RANKING ANALYSIS 101
9.3 COMPETITIVE SCENARIO 102
9.3.1 SERVICE LAUNCHES, UPGRADES, AND APPROVALS 103
9.3.2 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS 104
9.3.3 ACQUISITIONS 104
9.3.4 EXPANSIONS 105
10 COMPANY PROFILES 106
(Overview, Products Offered, Product Offering Scorecard, Business Strategy Scorecard, Recent Developments)*
10.1 MAYO MEDICAL LABORATORIES 106
10.2 LABCORP 112
10.3 QUEST DIAGNOSTICS 118
10.4 SPECTRA LABORATORIES 125
10.5 DAVITA HEALTHCARE PARTNERS 128
10.6 EUROFINS SCIENTIFIC 130
10.7 UNILABS 135
10.8 SYNLAB INTERNATIONAL 137
10.9 BIO-REFERENCE LABORATORIES 138
10.10 SONIC HEALTHCARE 140
10.11 CLINICAL REFERENCE LABORATORY 144
10.12 ACM MEDICAL LABORATORY 146
10.13 ADICON CLINICAL LABORATORY 148
10.14 CERBA HEALTHCARE 150
10.15 AMEDES HOLDING 153
10.16 LIFELABS MEDICAL LABORATORIES 155

*Details on MarketsandMarkets view, Overview, Products Offered, Product Offering Scorecard, Business Strategy Scorecard, and Recent Developments might not be captured in case of unlisted companies.
11 APPENDIX 158
11.1 DISCUSSION GUIDE 158
11.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 162
11.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 164
11.4 AVAILABLE CUSTOMIZATIONS 165
11.5 RELATED REPORTS 166
11.6 AUTHOR DETAILS 167

渋谷データカウント

渋谷データカウントは、最も信頼性が高く最新の調査分析レポートを確実に提供する経験豊富な調査専門家のグローバルチームが提供する、さまざまな業界のさまざまな市場調査レポートを提供する再販代理店です。

Recommended reports

+